Journal of Vascular Surgery
Volume 48, Issue 5 , Pages 1166-1174 , November 2008

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease

Presented at the Thirty-sixth Annual Symposium, Society for Clinical Vascular Surgery, Las Vegas, Nev, Mar 5-8, 2008.

  • Hasan H. Dosluoglu, MD

      Affiliations

    • Division of Vascular Surgery, Department of Surgery, VA Western New York Healthcare System, Buffalo, NY
    • State University of New York at Buffalo, Buffalo, NY
    • Corresponding Author InformationCorrespondence: Hasan H. Dosluoglu, MD, Chief, Division of Vascular Surgery, VA Western NY Healthcare System, 3495 Bailey Ave, Buffalo, NY, 14215
    • ,
  • Gregory S. Cherr, MD

      Affiliations

    • State University of New York at Buffalo, Buffalo, NY
    • ,
  • Purandath Lall, MBBS

      Affiliations

    • Division of Vascular Surgery, Department of Surgery, VA Western New York Healthcare System, Buffalo, NY
    • State University of New York at Buffalo, Buffalo, NY
    • ,
  • Linda M. Harris, MD

      Affiliations

    • State University of New York at Buffalo, Buffalo, NY
    • ,
  • Maciej L. Dryjski, MD

      Affiliations

    • State University of New York at Buffalo, Buffalo, NY

Received 4 April 2008 ,Accepted 2 June 2008.

References 

  1. Surowiec SM, Davies MG, Eberly SW, Rhodes JM, Illig KA, Shortell CK, et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg. 2005;41:269–278
  2. Gray BH, Olin JW. Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease. Sem Vasc Surg. 1997;10:8–16
  3. Cheng SWK, Ting ACW, Ho P. Angioplasty and primary stenting of high-grade, long-segment disease: is it worthwhile?. Ann Vasc Surg. 2003;17:430–437
  4. Lugmayr HF, Holzer H, Kastner M, Riedelsberger H, Auterith A. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a mid-term follow-up. Radiology. 2002;222:37–43
  5. Sabeti S, Mlekusch W, Amighi J, et al. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther. 2005;12:6–12
  6. Ferreira M, Lanziotti L, Monteiro M, Abuhadba G, Capotorto LF, Nolte L, et al. Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg. 2007;34:702–708
  7. Meuwissen MW. Self-expanding nitinol stents in the femoropopliteal segment; technique and mid-term results. Tech Vasc Interv Radiol. 2004;7:2–5
  8. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in superficial femoral artery. N Engl J Med. 2006;354:1879–1888
  9. Schlager O, Dick P, Sabeti S, Amighi J, Mlekusch W, Minar E, et al. Long-segment SFA stenting–the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther. 2005;12:676–684
  10. Loftus IM, Hayes PD, Bell PR. Subintimal angioplasty in lower limb ischemia. J Cardiovasc Surg (Torino). 2004;45:217–229
  11. Laxdal E, Jenssen GL, Pedersen G, Aune S. Subintimal angioplasty as a treatment of superficial femoral artery occlusions. Eur J Vasc Endovasc Surg. 2003;25:578–582
  12. Yilmaz S, Sindel T, Yegin A, Luleci E. Subintimal angioplasty of long superficial femoral artery occlusions. J Vasc Interv Radiol. 2003;14:997–1010
  13. Lipsitz EC, Veith FJ, Ohki T. The value of subintimal angioplasty in the management of critical lower extremity ischemia: failure is not always associated with a threatened limb. J Cardiovasc Surg (Torino). 2004;45:231–237
  14. Hynes N, Akhtar Y, Manning B, Aremu M, Oiakhinan K, Courtney D, et al. Subintimal angioplasty as a primary modality in the management of critical limb ischemia; Comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease. J Vasc Ther. 2004;11:460–471
  15. Flørenes T, Bay D, Sandbaek G, Saetre T, Jørgensen JJ, Slagsvold CE, et al. Subintimal angioplasty in the treatment of patients with intermittent claudication: long term results. Eur J Vasc Endovasc Surg. 2004;28:645–650
  16. Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective randomized trial. J Vasc Interv Radiol. 2003;14:303–311
  17. Lammer J, Dake MD, Bleyn J, Katzen BT, Cejna M, Piquet P, et al. Peripheral arterial obstruction: Prospective study of treatment with a transluminally placed self-expanding stent graft (International Trial Study Group). Radiology. 2000;217:95–104
  18. Deutschmann HA, Schedlbauer P, Berczi V, Portugaller H, Tauss J, Hausegger KA. Placement of Hemobahn stent graft in femoropopliteal arteries: early experience and mid-term results in 18 patients. J Vasc Interv Radiol. 2001;12:943–950
  19. Ko YG, Kim JS, Choi DH, Jang Y, Shim WH. Improved technical success and midterm patency with subintimal angioplasty compared to intraluminal angioplasty in long femoropopliteal occlusions. J Endovasc Ther. 2007;14:374–381
  20. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD) (TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)). J Vasc Surg. 2000;31:S1–S296
  21. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S67
  22. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vac Surg. 2007;45:10–16
  23. Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003;37:149–155
  24. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral femoropopliteal bypasses. Surgery. 1999;126:594–601
  25. Ballotta E, Renon L, Toffano M, Da Giau G. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein. J Vasc Surg. 2003;38:1051–1055
  26. Veith FJ, Gupta SK, Ascher , White-Flores S, Samson SH, Scher LA, et al. Six-year, prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3:104–114
  27. Prendiville EJ, Yeager A, O'Donnell TF, Coleman JC, Jaworek A, Callow AD, et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg. 1990;11:517–524
  28. Klinkert P, Post PN, Breslau PN, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass: a review of the literature. Eur J Vasc Endovasc Surg. 2004;27:357–362
  29. Pereira CE, Albers M, Romiti M, Brochado-Neto FC, Pereira CAB. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg. 2006;44:510–517
  30. Ahn SS, Rutherford RB, Becker GJ, Comerota AJ, Johnston KW, McClean GK, et al. Reporting standards for lower extremity arterial endovascular procedures (Society for Vascular Surgery/International Society for Cardiovascular Surgery). J Vasc Surg. 1993;17:1103–1107
  31. DeRubertis BG, Pierce M, Chaer RA, Rhee SJ, Benjeloun R, Ryer EJ, et al. Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention. J Vasc Surg. 2007;46:709–716
  32. Kudo T, Chandra FA, Ahn SS. The effectiveness of PTA for the treatment of CLI: a 10 year experience. J Vasc Surg. 2005;41:423–435
  33. Bakken AM, Palchik E, Hart JP, Rhodes JM, Saad WE, Davies MG. Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg. 2007;46:946–958
  34. Conrad MF, Cambria RP, Stone DH, Brewster DC, Kwolek CJ, Watkins MT, et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg. 2006;44:762–769
  35. DeRubertis BG, Pierce M, Ryer EJ, Trocciola S, Kent KC, Faries PL. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg. 2008;47:101–108
  36. Lazaris AM, Tsiamis AC, Fishwick G, Bolia A, Bell PR. Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients with critical limb ischemia. J Endovasc Ther. 2004;11:447–453
  37. Dick F, Diehm N, Galimanis A, Husmann M, Schimidli J, Baumgartner I. Surgical and endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg. 2007;45:751–761
  38. Galaria II, Surowiec SM, Rhodes JM, Shortell CK, Illig KA, Davies MG. Implications of early failure of superficial femoral artery endoluminal interventions. Ann Vasc Surg. 2005;19:787–792
  39. Joels CS, York JW, Kalbaugh CA, Cull DL, Langan EM, Taylor SM. Surgical implications of early failed endovascular intervention of the superficial femoral artery. J Vasc Surg. 2008;47:562–565

 Competition of interest: none.

PII: S0741-5214(08)00937-3

doi: 10.1016/j.jvs.2008.06.006

Journal of Vascular Surgery
Volume 48, Issue 5 , Pages 1166-1174 , November 2008

Article Tools

* Image Usage & Resolution